Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is a sensory-motor neurological disorder with a circadian component. RLS is characterized by uncomfortable sensations in the extremities, generally at night or during sleep, which often leads to an uncontrollable urge to move them for relief. Recently, genomic studies identified single nucleotide polymorphisms in BTBD9, along with three other genes, as being associated with a higher risk of RLS. Little is known about the function of BTBD9 or its potential role in the pathophysiology of RLS. We therefore examined a line of Btbd9 mutant mice we recently generated for phenotypes similar to symptoms found in RLS patients. We observed that the Btbd9 mutant mice had motor restlessness, sensory alterations likely limited to the rest phase, and decreased sleep and increased wake times during the rest phase. Additionally, the Btbd9 mutant mice had altered serum iron levels and monoamine neurotransmitter systems.
Introduction
Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is a common neurological disorder that has a motor, sensory, and a circadian component. It is characterized by an uncontrollable urge to move the legs for relief, generally accompanied by an unpleasant sensation in the legs, with an increase in symptoms during rest or at night (1) (2) (3) (4) . RLS affects approximately 3 to 10% of the general population, with women generally having higher rates than men (2) . The symptoms of RLS often lead to sleep disturbances, and can severely affect the patient's daytime function and quality of life (5) . The primary treatment for RLS is dopaminergics (6, 7) , but can also include opioids (8, 9) , anticonvulsants (10, 11) , or iron supplementation (12) (13) (14) (15) .
In approximately 60% of RLS cases there is a family history of RLS (16) (17) (18) (19) (20) . Moreover, evaluations of 12 identical twin pairs in which one or both members have RLS, a concordance rate of 83.3% was found, suggesting a high genetic component (21) . Recently, two genome wide association studies (GWAS) were performed with the aim of identifying polymorphisms in genes that are highly associated with RLS if any existed. In these two studies single nucleotide polymorphisms (SNPs), which are single nucleotide variations that exist naturally within the human population, in four genes were found to impart varying increased risk of having RLS.
The genes identified were MEIS1, MAP2K5, PTPRD, and BTBD9 (22, 23) . As SNPs in BTBD9 were found to impart an increased susceptibility to RLS in both studies, it made for an excellent candidate gene to study. BTBD9 has two highly conserved domains, a BTB/POZ domain and a BACK domain, which have been associated with transcriptional regulation, cytoskeleton dynamics, and protein ubiquitination (24, 25) . Previously, a polymorphism in BTBD9 that has been associated with an increased risk for RLS was correlated with decreased serum iron levels (23). Furthermore, a quantitative trait loci (QTL) including Btbd9 was associated with ventral midbrain iron levels (26) . However, little is known about the normal function of BTBD9 and how it could potentially be involved in the pathophysiology of RLS.
Additionally, efforts have been made to generate and characterize animal models of RLS.
These have included iron deficient mice (27) (28) (29) (30) (31) , lesioning of either the A11 dopaminergic nucleus (32) (33) (34) (35) (36) or the spinal cord at the T9 level (37) , and D3 dopamine receptor knockout mice (31, 38, 39) . However, as others have noted, these phenotypic models lack clear etiology or symptomology with RLS, thereby limiting their potential utility (40) . For instance, no neurodegeneration or gross abnormalities have been found in the A11 dopaminergic nucleus in RLS patients compared to control (41) . Additionally, no mutations or polymorphisms in D3DR, the gene encoding the D3 dopamine receptor, or systemic loss of the D3 dopamine receptor have bee reported in RLS patients to date. This therefore suggests that the D3 dopamine receptor knockout mice, though a genetically modified line of mice, are a phenotypic mouse model and not a genotypic mouse model of RLS. In this study, we aimed to examine a line of Btbd9 mutant mice we recently generated to explore its potential utility as a genotypic mouse model of RLS (42) . As direct application of standard diagnostic methods for RLS (e.g. IRLSSG rating scale)
are not feasible, we thoroughly examined the Btbd9 mutant mice for similar, relevant phenotypes.
We found that the Btbd9 mutant mice had motor restlessness, both in voluntary activity and total activity, thermal sensory alterations likely limited to the rest phase, and decreased sleep time and increased wake time during the rest phase. Furthermore, we have found that the Btbd9 mutant mice had elevated levels of iron in the serum and alterations in the monoamine neurotransmitter system. Therefore, these results suggest that the loss of Btbd9 in mice results in behavioral and by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from biochemical abnormalities that have particular relevance to RLS, including motor activity, sensory, and levels of monoamine and iron. Furthermore, we have found that the thermal sensory alterations in the Btbd9 mutant mice can be relieved using the dopaminerigic D2 receptor-like agonist ropinirole, which is a common treatment for RLS patients. These results taken together suggest that BTBD9 is involved in RLS, and further studies of the Btbd9 mutant mice are warranted to examine its role in RLS pathophysiology.
Results

Motor restlessness in Btbd9 mutant mice
A cardinal feature of restless legs syndrome (RLS) is a desire to move. Previous phenotypic mouse models of RLS have shown altered activity levels, including hyperactivity and PLM-like phenomena (32, 37, 38) . Therefore, to assess the total activity levels of the Btbd9 mutant mice we measured activity using an open field activity chamber. We found that the homozygous Btbd9 mutant mice had an increased total distance traveled compared to wild-type Table 1 ). The results suggest that the homozygous Btbd9 mutant mice are hyperactive. Furthermore, alterations in circling behavior in mice have been linked in other studies to imbalances in the dopaminergic system (43, 44) .
Next, we assessed wheel running activity, which measures voluntary activity in a home cage ( Figure 2 ). In normal 12 hour light, 12 hour dark conditions (LD), homozygous Btbd9 mutant mice exhibited a strong trend of increase in total counts, which are the counts during both day and night (Table 1 , p = 0.06), and a trend of increase in counts during the lights on phase, when the mice would normally be resting or sleeping (Table 1 , p = 0.08). Next, the mice were placed in constant darkness (DD), which mice typically respond with increased activity. We found that the homozygous Btbd9 mutant mice exhibited an increased in activity compared to WT mice (Table 1, p < 0.05). Additionally, we found that there are no significant alterations in circadian parameters, including period, alpha, or amplitude in either normal LD or DD (p > 0.05, Table 1 ). This data, taken together, suggest that there is an increase in voluntary activity that corroborates the previous finding of total activity being increased in the homozygous Btbd9 mutant mice ( Figure 1A ).
Thermal sensory alterations in Btbd9 mutant mice
Commonly associated with the urge to move in RLS patients are uncomfortable sensations in the legs. Therefore, we tested the Btbd9 mutant mice for abnormalities in the sensory system using the tail flick test. Heterozygous Btbd9 mutant mice had a 27% decrease in time to respond to the warm stimulus ( Figure 3A , p < 0.05). Furthermore, the homozygous Btbd9 mutant mice had a 53.4% decrease in time to respond to the warm stimulus ( Figure 3A , p < 0.01). We further dissected this sensory alteration in the heterozygous Btbd9 mutant mice, as they may represent more of the RLS population, and showed an intermediary deficit. We observed that the heterozygous Btbd9 mutant mice had no significant sensory alteration compared to WT mice during the middle of the active phase ( Figure 3B -Midnight, p > 0.05).
However, there was a significant sensory alteration in the heterozygous Btbd9 mutant mice during the middle of the rest phase in comparison to WT mice ( Figure 3B receptor-like dopaminergic agonist given to RLS patients (6, (45) (46) (47) (48) (49) (50) (51) . This treatment was able to rescue the sensory alterations at 15 minutes post-injection (PI), 30 minutes PI, and 60 minutes PI ( Figure 3B , p > 0.05). These taken together, suggest that the Btbd9 mutant mice have a circadian-dependent sensory deficit. More importantly, this sensory deficit is responsive to dopaminergic treatment.
Sleep structure alterations in Btbd9 mutant mice
Due to the uncomfortable sensations in the legs and the uncontrollable urge to move, patients with RLS often will have fragmented sleep (52-54). To investigate if similar sleep disruptions occur in the homozygous Btbd9 mutant mice, we implanted homozygous Btbd9 mutant mice and WT mice with a wireless telemetry system capable of electroencephalographic (EEG) and electromyographic (EMG) recordings of the right tibialis cranialis, which is equivalent to the tibialis anterior muscle in humans. We observed, similarly, that during the rest phase the homozygous Btbd9 mutant mice had decreased slow-wave sleep (SWS) ( Table 2 , p < 0.01), no statistical difference in REM sleep ( Table 2 , p > 0.05), and an increased awake time (Table 2 , p < 0.05) compared to WT mice. Furthermore, there was an increase in arousals in the homozygous Btbd9 mutant mice compared to WT mice (Table 2, p < 0.05), but no significant alteration in latency to sleep or REM sleep ( Table 2 , p > 0.05). These results, taken together, suggest that there is an imbalance in the normal sleep architecture of the Btbd9 mutant mice, similar to RLS patients.
Altered iron metabolism in Btbd9 mutant mice
Analysis of the iron system has been an emphasis of RLS research. Therefore to test whether the Btbd9 mutant mice have an alteration in iron homeostasis, we measured serum iron using a colorimetric assay. We found that the homozygous Btbd9 mutant mice have an increase in iron levels in the serum ( Figure 4A , p < 0.01). We then performed atomic absorption (AA) spectroscopy of homozygous Btbd9 mutant mice striatum, a critical region of the basal ganglia in the brain. We found that there was no statistical difference in striatal brain iron levels between homozygous Btbd9 mutant mice and WT mice ( Figure 4B , p > 0.05). These results taken together suggest that there is an imbalance in the iron homeostasis, at least in the periphery of the Btbd9 mutant mice.
Altered serotonergic metabolism in Btbd9 mutant mice
Another biochemical aspect of RLS that has been a focus of study in RLS is the monoamine neurotransmitter systems. We analyzed the striatum of homozygous Btbd9 mutant mice using high performance liquid chromatography (HPLC) for alterations in dopamine (DA); serotonin (5-HT); and their metabolites 3,4-dihyroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA). We observed no statistical difference between homozygous Btbd9 mutant mice and WT mice in dopamine, serotonin, DOPAC, and HVA (Table 3 , p > 0.05). However, we did find an increase in 5-HIAA, a metabolite of serotonin, in the homozygous Btbd9 mutant mice compared to WT (Table 3 , p < 0.05). This suggests that while the gross levels of dopamine and serotonin are not altered, there may be alterations in the metabolism of the monoamine neurotransmitters in the striatum.
Discussion
In this study we examined a line of mutant mice lacking the complete Btbd9 protein for behavioral and biochemical deficits that could potentially be related to restless legs syndrome (RLS), as recent genomic studies have suggested that polymorphisms in BTBD9 impart an increased risk of having RLS. We found that Btbd9 mutant mice had motor restlessness including increased total activity, voluntary activity, and wake time and arousals during the rest phase. Furthermore, the Btbd9 mutant mice had alterations in thermal sensory perception that was likely limited to the rest phase. Additionally, this sensory alteration could be rescued using ropinirole, a common dopaminergic agonist used to treat RLS patients. Finally, we examined the iron levels and monoamine neurotransmitter systems in the Btbd9 mutant mice to examine potential molecular bases for these deficits, and found an elevated level of iron in blood serum, an increase in the serotonin metabolite 5-HIAA, and a preferential alteration in circling behavior.
Previous phenotypic models of RLS have shown motor restlessness or alterations in sleep efficiency. These include lesioning of the A11 dopaminergic nucleus in rats, which showed increased standing episodes and increased arousal from sleep compared to sham operated rats (32, 36) . In another study, a transverse spinal cord lesion at the T9 level in rats showed decreased sleep efficiency and the appearance of pseudo-periodic gastrocnemious activation during sleep (37) . Lastly, a mouse lacking the D3 dopamine receptor was found to have hyperactivity (38) .
Our Btbd9 mutant mice, similarly, have an increased voluntary activity, total activity, and increased wake time and arousal during the rest phase. We speculate that this hyperactivity either parallels the symptoms of RLS, in that the animals are more active due to uncontrollable urges to move, or the symptoms of attention deficit hyperactivity disorder (ADHD) in step with the finding that there is comorbidity between RLS and ADHD (55) (56) (57) (58) (59) (60) (61) . As the hyperactivity has been observed during the rest phase in both our Btbd9 mutant mice and other models, this would lend support to hypothesis that the hyperactivity arises from an RLS-like phenotype. However, further studies will need to be conducted to examine whether the Btbd9 mutant mice have ADHD-like phenotypes as well.
Sensory symptoms have been reported in a number of studies on RLS patients (62-66), including thermal sensory alterations (67, 68) . Furthermore, recent studies in the D3 dopamine receptor knockout mice have shown increased sensitivity to acute and persistent pain (31) .
Comparably, our homozygous Btbd9 mutant mice had a thermal sensory alteration. Our finding also parallels a study conducted on RLS patients showing that immobility increases sensory deficits (69), as our tail flick experiment was conducted on restrained mice. Furthermore, we showed that heterozygous Btbd9 mutant mice have sensory alterations, though to a lesser extent than the homozygous Btbd9 mutant mice, suggesting a relationship between Btbd9 expression and thermal sensory perception. Additionally, we showed that heterozygous Btbd9 mutant mice have no significant sensory alteration during the middle of the active phase, but do have significant sensory alterations during the middle of the rest phase. This is similar to RLS patients, as symptoms predominately occur during rest or while sleeping. However, one report suggest that pain in response to mechanical stimulation in RLS patients is altered both during the day and night (66). However, it is possible that mechanical and thermal stimulation are processed differently. Furthermore, the majority of the patients in this study lacked a familial history of RLS, thereby potentially causing heterogeneity in the study population. Finally, we show that the sensory alteration in heterozygous Btbd9 mutant mice can be rescued by a single injection of ropinirole, a common dopaminergic treatment for RLS patients (6) . Taken together, the Btbd9 mutant mice have a sensory alteration that is likely limited to the rest phase, which can be rescued using ropinirole, similarly to RLS patients. Additional experiments will need to be conducted to determine the mechanisms that underlie this dopaminergic rescue and the effects of other RLS treatments.
To elucidate a possible biochemical mechanism underlying the behavioral deficits, we also examined the iron and monoamine neurotransmitter systems. Iron homeostasis has been a major area of research in RLS. Primarily, iron anemia or related conditions have been associated with RLS (70) . Interestingly, we found in our Btbd9 mutant mice an increase in iron levels in the serum. Furthermore, we found that there was no change in iron levels in the striatum in the Btbd9 mutant mice. Further studies will need to be conducted to examine whether proteins involved in iron regulation are altered or whether iron is present in correct cell types in the Btbd9 mutant mice. It is worth noting as well that while iron anemia may be a common occurrence in RLS patients, not all patients with iron anemia have RLS (71) . Furthermore, RLS has been reported in patients with familial hemochromatosis, which causes excess iron in the body (72, 73) .
Lastly, we also examined the monoamine neurotransmitter system using high performance liquid chromatography (HPLC) on striatal brain tissue. In RLS patients, varying results have been found on the dopaminergic and serotonergic system. Two studies have shown that there are no alterations in levels dopamine, serotonin, or their metabolites in cerebrospinal fluid (CSF) of RLS patients (74, 75) , while a third showed a decrease in 5-hydroxyindoleacetic acid (5-HIAA), a metabolite of serotonin, and tetrahydrobiopterin (BH4), an essential cofactor for the biosynthesis of the monoamine neurotransmitters, in CSF of RLS patients (76) . We found that in the striatum of our Btbd9 mutant mice there was no difference in dopamine, serotonin, or dopamine metabolites, but an increase in the serotonin metabolite 5-HIAA. We also found that the Btbd9 mutant mice have a preferential increase in circling behavior, which has been shown in other mouse models to be related to dopaminergic imbalance, in particular that arising from the striatum (43, 44) . Lastly, the Btbd9 mutant mice showed sensory alterations that can be rescued by ropinirole, which targets the dopaminergic system. Taken together, these results suggest an altered dopaminergic system in addition to serotonergic system in the Btbd9 mutant mice. Further studies will need to be conducted on the serotonergic and dopaminergic systems to better understand the nature of these alterations.
In conclusion, we propose that the Btbd9 mutant mice model several aspects similar to an RLS-like phenotype, including motor restlessness, sensory alterations, imbalances in iron homeostasis, and alterations in the monoamine neurotransmitter systems, and therefore would be the first genotypic model of RLS. Furthermore, speculation has arisen about whether BTBD9 is involved in RLS or whether its neighboring gene, GLO1, is in fact the true susceptibility gene (77) . Our data suggest that BTBD9 is involved in the pathophysiology of RLS, and further research will need to be conducted to examine how these behavioral deficits arise and the role of BTBD9 in the pathophysiology of RLS. Finally, as the Btbd9 mutant mice can be treated with dopaminergic treatments to rescue a sensory alteration, this supports the utility of this line of mice as a model of RLS, and an animal model to discover and screen potential novel therapeutics.
Materials and Methods
All experiments were carried out in compliance with the USPHS Guide for Care and Use of Laboratory Animals and approved by the Institutional Animal Use and Care Committee at the University of Alabama at Birmingham.
Mice
We previously generated a line of Btbd9 mutant mice were using a commercially 
Open field
by guest on November 4, 2016 An open field apparatus was used to measure total activity and circling behaviors, as previously described (79) (80) (81) , in five homozygous Btbd9 mutant mice and 16 WT mice. In brief, the open field apparatus (Lafayette Instruments) is equipped with infrared sensors that detect breaks in the beams. Software (DigiScan Systems, AccuScan Instruments) is then used to decode these beam breaks into varying behavioral patterns. This experiment was performed with 30 min of observation time during the rest phase.
Wheel running
Seven male homozygous Btbd9 mutant mice and seven male WT mice were maintained on a 12 hour light, 12 hour dark (LD) cycle for 17 days, and then followed by 17 days of constant darkness (DD). Wheel running activity was recorded as the number of wheel revolutions occurring during 5 min bins and analyzed using ClockLab software (Actimetrics).
For the last 10 days in LD, the proportions of activity during lights on and lights off, as well as the total amount of activity per day and alpha length (time between onset and offset of primary activity bout) were determined. The activity profile feature of ClockLab was used to determine the proportion of activity over the course of the LD cycle averaged over a 7 day period. The averaged data for each animal was normalized to the maximum activity for that animal. Means from each group across 24 hr is shown in Figure 2 . For statistical comparison, data were binned into 3 hour bins and analyzed with a two-way repeated measures ANOVA. In DD, activity was measured for the entire 17 days and ClockLab was used to determine average counts per minute, alpha length. In addition, the chi-squared periodogram analysis in ClockLab was used to determine period and rhythmic power as a measure of the amplitude and coherence of behavioral rhythms (82, 83) . Six heterozygous Btbd9 mutant mice, five homozygous Btbd9 mutant mice, and 16 WT mice were tested for perception of warm stimuli using the Tail Flick Analgesia Meter (San Diego Instruments). The experiment was performed as previously described (84) . In brief, the mouse was placed in an acrylic restrainer with the distal end of its tail protruding under a heat lamp, which was then manually turned on alongside a timer. Both the heat lamp and timer stopped automatically when the mouse produced a strong reaction to the heat by moving its tail away from the light. The latency to respond was limited to 15 s to prevent injury to the mouse. 
Polysomnography
To measure sleep architecture in the Btbd9 mice, three male homozygous Btbd9 mutant mice and three male WT mice were implanted with a wireless telemetry system (DSI Instruments). The mice were anesthetized and a small vertical cut (approximately 1 cm) was made on one side of the skin near the hind limb and the tibialis cranialis muscle was localized. A pair of leads were then inserted into the muscle and sutured and glued in place to obtain electromyographic (EMG) data. Another pair of leads was placed on the dura of the brain to obtain electroencephalographic (EEG) data, as suggested by the manufacturer, and dental cemented in place. The body of the transmitter and any excess wire were inserted under the back of the skin and sutured close. The mice were then allowed 48 hr to recover from surgery (Supplementary Video 1). The EEG and EMG signals were processed and sleep patterns analyzed by NeuroScore computer software (DSI Instruments).
Colorimetric assay for serum iron
Blood was collected by retro-orbital blood collection using a glass pipette on four homozygous Btbd9 mutant mice and three WT mice. The blood was allowed to clot and then separated by centrifugation at 1,500×g for 10 min. The serum was removed and centrifuged again at 1,500×g for 10 min for further purification. The iron concentration was quantified using a colorimetric assay (QuantiChrom Iron Assay Kit, BioAssay Systems Inc.), according to manufacturer's instructions.
Atomic absorption spectroscopy for iron in striatal tissue
Striatum from seven homozygous Btbd9 mutant mice and seven WT mice were dissected out and homogenized 1:10 in PBS (pH 7.4) containing protease inhibitors (Roche). Brain region aliquots were wet digested by published and standard procedures and analyzed for iron concentration by atomic absorption spectrometry (Perkin Elmer AAnalyst 600, Perkin Elmer) (85) . Standards were prepared by diluting a Perkin Elmer iron standard (PE#N9300126) in 0.2% ultra-pure nitric acid, and blanks prepared with digesting and diluting reagents to control for possible contamination. All standard curves exceeded r > 0.99.
High performance liquid chromatography (HPLC)
Homogenate from the same striatal samples used for iron measurements was aliquoted for HPLC analysis. The homogenate (50 mL), 0.24 M perchloric acid (50 mL) and internal standard 
